ctrl K

Boston Scientific Corpora... (BSX)

NYSE: BSX · Real-Time Price · USD

103.77

0.90 (0.87%)

At close: May 01, 2025, 2:15 PM

Boston Scientific Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	16.75B	14.24B	12.68B	11.89B	9.91B	10.73B	9.82B	9.05B	8.39B
Cost of Revenue	5.26B	4.34B	4B	3.76B	3.51B	3.18B	2.88B	2.66B	2.5B
Gross Profit	11.49B	9.89B	8.68B	8.13B	6.4B	7.55B	6.94B	6.39B	5.88B
Operating Income	2.6B	2.34B	1.65B	2.04B	1.04B	1.52B	1.51B	1.28B	447M
Interest Income	107M	22M	10M	4M	3M	30M	3M	5M	5M
Pretax Income	2.28B	1.99B	1.14B	1.08B	-138M	687M	1.42B	933M	177M
Net Income	1.85B	1.59B	698M	1.04B	-140M	4.7B	1.67B	104M	347M
Selling & General & Admin	5.98B	5.19B	4.52B	4.36B	3.79B	3.94B	3.57B	3.29B	3.1B
Research & Development	1.61B	1.41B	1.32B	1.2B	1.14B	1.17B	1.11B	997M	920M
Other Expenses	1.29B	948M	803M	741M	789M	699M	156M	-124M	-37M
Operating Expenses	8.89B	7.55B	6.65B	6.3B	5.72B	5.81B	5.28B	4.86B	4.56B
Interest Expense	305M	265M	470M	341M	361M	473M	241M	229M	233M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	14.14B	11.9B	10.65B	10.06B	9.23B	8.99B	8.16B	7.52B	7.07B
Income Tax Expense	436M	393M	443M	36M	2M	-4.01B	-249M	828M	-170M
Shares Outstanding (Basic)	1.47B	1.45B	1.43B	1.42B	1.42B	1.39B	1.38B	1.37B	1.36B
Shares Outstanding (Diluted)	1.49B	1.46B	1.44B	1.43B	1.42B	1.41B	1.4B	1.39B	1.38B
EPS (Basic)	1.26	1.08	0.45	0.69	-0.1	3.38	1.21	0.08	0.26
EPS (Diluted)	1.25	1.07	0.45	0.69	-0.1	3.33	1.19	0.07	0.25
EBITDA	2.6B	3.45B	2.74B	2.52B	1.51B	2.21B	2.58B	2.01B	1.23B
EBIT	2.59B	2.25B	1.61B	1.42B	282M	1.2B	1.66B	1.16B	410M
Depreciation & Amortization	16M	1.2B	1.14B	1.09B	1.12B	1.01B	894M	844M	815M